Cystatin C (with eGFR) is a blood test that measures cystatin C, a small protein produced steadily by nearly all cells and removed exclusively by kidney filtration. Because it’s filtered out only by the kidneys, cystatin C reflects glomerular filtration rate (GFR). The lab uses the cystatin C value to estimate your eGFR, indicating how efficiently your kidneys filter waste and maintain fluid, electrolyte, and acid-base balance.

Cystatin C-based eGFR is often more accurate than creatinine-based eGFR because cystatin C is less influenced by muscle mass, diet, age-related muscle loss, or sex. Creatinine can look “normal” in people with low muscle mass or unusual diets even when kidney function is declining. Using cystatin C helps clarify true kidney filtering power, especially in older adults, people with sarcopenia, or those with chronic conditions.

Cystatin C can detect early or subtle kidney decline before creatinine rises, especially when creatinine may be misleading due to low muscle mass, aging, or diet differences. It provides a clearer signal of reduced GFR and can “unmask” hidden kidney stress even before symptoms like fatigue or swelling appear. It’s commonly used to confirm kidney function when creatinine-based eGFR doesn’t match the overall clinical picture.

Key benefits include more accurate assessment of kidney filtering power, earlier detection of decline, and improved confidence when creatinine is distorted by muscle mass or diet. It helps track kidney health over time in diabetes, hypertension, and heart disease. Cystatin C-based eGFR can also flag kidney stress before symptoms appear, supporting earlier interventions to protect long-term kidney and cardiovascular health.

Typical cystatin C levels are about 0.5 to 1.0 mg/L, with optimal values often toward the lower end. For eGFR, a cystatin C-based eGFR above 90 mL/min/1.73m² generally reflects normal kidney function across most age groups. Baselines can differ slightly in children and pregnancy due to physiologic changes, so interpretation should be individualized and aligned with the full clinical picture.

A high cystatin C often signals reduced kidney filtration and may appear earlier than creatinine changes. This can indicate early chronic kidney disease, acute kidney injury, or reduced kidney reserve related to diabetes, hypertension, or autoimmune conditions. Because creatinine can be falsely reassuring in people with low muscle mass or diet differences, combining cystatin C with creatinine-based eGFR can improve accuracy and better reflect true GFR.

Low cystatin C usually reflects strong kidney filtration and efficient clearance, which can be seen in younger adults and athletes. Very low values may also occur with hyperthyroidism or corticosteroid use, which can increase filtration rate. In some contexts, low cystatin C may relate to reduced protein turnover (such as malnutrition or muscle loss) rather than kidney health. Results are best interpreted alongside eGFR and clinical context.

Several non-kidney factors can influence cystatin C interpretation, including thyroid dysfunction, inflammation, obesity, and certain medications. These factors can shift cystatin C independent of true GFR. Because of this, clinicians often interpret cystatin C-based eGFR alongside creatinine-based eGFR and other clinical information to reduce the risk of misclassification and to better estimate actual kidney filtering capacity.

Accurate eGFR is important for adjusting medication dosing to avoid drug-related kidney harm. Cystatin C-based eGFR can provide a clearer estimate of kidney filtration when creatinine is unreliable, helping clinicians choose safer doses and reduce the risk of toxicity from medications cleared by the kidneys. This is especially helpful in older adults, people with low muscle mass, and patients with diabetes, hypertension, or heart disease.

No single marker is perfect in all situations. While cystatin C is less affected by muscle mass and diet, it can be influenced by thyroid dysfunction, inflammation, obesity, and some medications. Creatinine has different limitations. Interpreting cystatin C-based eGFR alongside creatinine-based eGFR provides a more reliable estimate of true GFR and aligns results with symptoms, risk factors (like diabetes or hypertension), and the full clinical picture.